Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
IOL Chemicals & Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524164NSE Symbol: IOLCPP/E(TTM):32.36
ISIN Demat:INE485C01029Div & Yield %:0.69EPS(TTM):3.59
Book Value(Rs):57.487133Market Cap ( Cr.):3409.91Face Value(Rs):2
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 2079.212132.792217.112184.021966.981894.47
Excise Duty0.000.000.000.000.000.00
Net Sales2079.212132.792217.112184.021966.981894.47
Other Income 22.4030.0725.5732.0424.3016.02
Stock Adjustments -33.5138.2518.2052.3017.11-20.96
Total Income2068.102201.112260.882268.362008.391889.53
EXPENDITURE :      
Raw Materials 1358.341435.201565.291622.811119.951044.05
Power & Fuel Cost114.93149.05131.9878.1851.4665.12
Employee Cost 216.57201.02168.21141.30115.5597.20
Other Manufacturing Expenses 47.3947.6743.0736.8628.1328.37
Selling and Administration Expenses 70.2960.2468.3771.9655.2651.31
Miscellaneous Expenses 36.0146.3431.8742.8621.9013.58
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1843.531939.522008.791993.971392.251299.63
Operating Profit224.57261.59252.09274.39616.14589.90
Interest 14.7616.1016.478.295.8320.93
Gross Profit209.81245.49235.62266.10610.31568.97
Depreciation71.9262.8546.1343.2638.9235.73
Profit Before Tax137.89182.64189.49222.84571.39533.24
Tax24.7437.0146.2657.01145.55170.90
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax12.1510.213.250.17-18.721.05
Reported Net Profit101.00135.42139.98165.66444.56361.29
Extraordinary Items -0.130.07-0.27-11.05-0.050.00
Adjusted Net Profit101.13135.35140.25176.71444.61361.29
Adjst. below Net Profit 0.000.000.000.000.000.00
P & L Balance brought forward1324.301218.231101.75971.31550.23209.51
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 23.4829.3523.5035.2223.4820.57
P & L Balance carried down1401.821324.301218.231101.75971.31550.23
Dividend23.4829.3523.5035.2223.4817.07
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %40.0050.0040.0040.0060.0030.00
Earnings Per Share-Unit Curr3.4423.0723.8428.2275.7263.51
Earnings Per Share(Adj)-Unit Curr3.4423.0723.8428.2275.7263.51
Book Value-Unit Curr57.48274.46256.61236.80214.69141.36